-- SSY Group's (HKG:2005) full-range C-reactive and Serum Amyloid A/C-reactive protein test kits obtained medical device registration certificates from the Hebei Provincial Drug Administration of China, according to a Wednesday Hong Kong bourse filing.
The kits are used for in vitro quantitative detection of C-reactive protein and serum amyloid A levels in human serum, plasma, or whole blood samples.